| 000 | 01586 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250517185128.0 | ||
| 264 | 0 | _c20190114 | |
| 008 | 201901s 0 0 eng d | ||
| 022 | _a1522-9629 | ||
| 024 | 7 |
_a10.1016/j.pupt.2017.11.007 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYuan, Qinghong | |
| 245 | 0 | 0 |
_aM _h[electronic resource] |
| 260 |
_bPulmonary pharmacology & therapeutics _c02 2018 |
||
| 300 |
_a144-150 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAcute Lung Injury _xdrug therapy |
| 650 | 0 | 4 |
_aCapillary Permeability _xdrug effects |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aCholinergic Antagonists _xpharmacology |
| 650 | 0 | 4 |
_aEndothelium, Vascular _xdrug effects |
| 650 | 0 | 4 | _aGene Knockdown Techniques |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLipopolysaccharides _xtoxicity |
| 650 | 0 | 4 |
_aMitogen-Activated Protein Kinases _xmetabolism |
| 650 | 0 | 4 |
_aQuinuclidines _xpharmacology |
| 650 | 0 | 4 |
_aReceptor, Muscarinic M3 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aTranscription Factor RelA _xmetabolism |
| 650 | 0 | 4 |
_ap38 Mitogen-Activated Protein Kinases _xmetabolism |
| 700 | 1 | _aXiao, Fei | |
| 700 | 1 | _aLiu, Qiangsheng | |
| 700 | 1 | _aZheng, Fei | |
| 700 | 1 | _aShen, Shiwen | |
| 700 | 1 | _aHe, Qianwen | |
| 700 | 1 | _aChen, Kai | |
| 700 | 1 | _aWang, Yanlin | |
| 700 | 1 | _aZhang, Zongze | |
| 700 | 1 | _aZhan, Jia | |
| 773 | 0 |
_tPulmonary pharmacology & therapeutics _gvol. 48 _gp. 144-150 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.pupt.2017.11.007 _zAvailable from publisher's website |
| 999 |
_c27808179 _d27808179 |
||